Beijing Foyou Pharma CO.,LTD

Equities

601089

CNE100005QF9

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
15.9 CNY -1.24% Intraday chart for Beijing Foyou Pharma CO.,LTD +1.02% -7.77%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Beijing Foyou Pharma CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Beijing Foyou Pharma CO.,LTD's Equity Buyback Plan announced on February 6, 2024. CI
Beijing Foyou Pharma CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Foyou Pharma Gets Nod for Ezetimibe and Simvastatin Tablets MT
Foyou Pharma Gets Nod for Cilostazol Tablets' Market Registration MT
Beijing Foyou Pharma CO.,LTD announces an Equity Buyback for CNY 200 million worth of its shares. CI
Beijing Foyou Pharma CO.,LTD authorizes a Buyback Plan. CI
Foyou Pharmaceutical Gets Nod for Registration of Fluvastatin Sodium Extended-Release Tablets MT
Beijing Foyou Pharmaceutical Gets Green Light to Test Clotrimazole Vaginal Tablets MT
Foyou Pharmaceutical Gets Nod for Marketing of Raw Drug Material for Anesthetic MT
Foyou Pharma Gets Nod to Market Roxadustat API MT
Beijing Foyou Pharma Gets Nod to Amend Production License MT
Beijing Foyou Pharma CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Beijing Foyou Pharma Gets Nod to Produce Telmisartan Hydrochlorothiazide Tablets MT
Beijing Foyou Pharma CO.,LTD(XSSC:601089) added to S&P Global BMI Index CI
Beijing Foyou Pharma CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Beijing Foyou Pharma CO.,LTD(SHSE:601089) added to Shanghai Stock Exchange Composite Index CI
Certain A Shares of Beijing Winsunny Pharmaceutical CO.,LTD are subject to a Lock-Up Agreement Ending on 1-JUL-2023. CI
Beijing Foyou Pharma CO.,LTD(SHSE:601089) added to Shanghai Stock Exchange A Share Index CI
Foyou Pharma Passes Drug GMP Compliance Inspection MT
Foyou Pharma Gets Certification for Diabetes Drug MT
Beijing Winsunny Pharmaceutical CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Foyou Pharma Registers Immunosuppressant Ointment in China MT
Beijing Winsunny Pharmaceutical CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Beijing Winsunny Pharmaceutical CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Chart Beijing Foyou Pharma CO.,LTD
More charts
Beijing Foyou Pharma Co Ltd, formerly Beijing Winsunny Pharmaceutical Co Ltd, is a China-based company mainly engaged in the research, development, production and sales of pharmaceutical preparations and medical devices. The Company's pharmaceutical preparations mainly cover the fields of cardiovascular system, chronic kidney disease, skin disease, digestive system, diabetes, mental nervous system, gynecology and others. The Company's pharmaceutical preparation products mainly include tablets, ointments, creams, gels, soft capsules, solutions, syrups, tinctures, sprays, hard capsules and others. The Company's medical device business focuses on humidification and oxygen inhalation devices, and its main products include disposable oxygen inhalation tubes and others. The Company mainly operates its businesses in the domestic and overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 601089 Stock
  4. News Beijing Foyou Pharma CO.,LTD
  5. Foyou Pharma Gets Nod for Cilostazol Tablets' Market Registration
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW